Evaluation of Enoxaparin Dosing in Hospitalized Morbidly Obese Patients at an Academic Medical Center

Trial Profile

Evaluation of Enoxaparin Dosing in Hospitalized Morbidly Obese Patients at an Academic Medical Center

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2017 Status changed from recruiting to completed.
    • 11 Apr 2016 Planned End Date changed from 1 Mar 2014 to 1 Mar 2018.
    • 11 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top